Team Consulting is introducing its new Occoris inhaler engine technology designed specifically for the delivery of API-only formulations for systemic therapies. The flexible Occoris system offers repeatable delivery of a wide range of dose sizes with no carrier necessary, Team says, facilitating pulmonary delivery of vaccines, analgesics, insulin, and other drugs.
Because the Occoris engine is extremely small, approximately the size of a pea, the company explains, designers have multiple options for inhaler design and materials, including the use of recyclable cardboard. At RDD, Team will be showing prototypes of three inhalers using the engine: a a single-use disposable inhaler, a multi-unit dose inhaler, and a multi-dose inhaler.
Team Consulting’s Head of Respiratory Drug Delivery David Harris commented, “With our Occoris technology we are opening up a wide range of new opportunities beyond the traditional and highly competitive asthma and COPD market, which will help our pharmaceutical clients to establish new revenue streams.” Harris adds that Team is in the process of optimizing the technology and that he is “looking forward to discussing the range of potential applications for the ground-breaking technology.”
Read the Team Consulting press release.
